메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Valproate is commonly used in various psychiatric and neurologic settings and is usually well tolerated. We present the case of a 26-year-old man who developed encephalopathy after valproate treatment. Ten days after initiating valproate therapy, he presented with a sudden decreased level of consciousness, disorientation, seizures, and eventually coma. Notably, the serum ammonia level was elevated to 392 μmol/l with no hepatic dysfunction on laboratory tests. He did not have a urea cycle-associated enzyme deficiency on tandem mass spectrometry. However, the free carnitine level was low (5 μmol/l), and this was suspected of being caused by the valproate treatment. Due to the possibility of valproate-induced hyperammonemic encephalopathy, the valproate was discontinued, and the patient was treated with L-carnitine 50 mg/kg per day. He recovered completely within 3 days of L-carnitine treatment, and the free carnitine level was within normal limits (53.5 μmol/l) 5 months thereafter. Clinicians should consider valproate-induced hyperammonemic encephalopathy in patients who present with any mental changes or atypical psychiatric symptoms while on valproate.

목차

등록된 정보가 없습니다.

참고문헌 (27)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0